Cell Line Tumor Xenograft (CDX) Modeling

Question: What are the advantages of using Cell Line-Derived Xenograft (CDX) models in oncology drug efficacy studies?

Answer: CDX models involve the transplantation of human cancer cell lines into immunocompromised mice, providing a reproducible and cost-effective platform for initial drug screening. Through professional CDX mouse modeling and pharmacodynamic services, researchers can monitor tumor growth kinetics, assess dose-response relationships, and analyze post-treatment biomarkers, ensuring that lead candidates demonstrate significant anti-tumor activity before progressing to more complex PDX models.